Australia markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.3100-0.3100 (-11.83%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.58-0.64-2.16-1.24
Low estimate-0.58-0.64-2.16-1.24
High estimate-0.58-0.64-2.16-1.24
Year ago EPS-0.84-0.71-2.62-2.16
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate1M1.19M4.95M10.28M
Low estimate1M1.19M4.95M10.28M
High estimate1M1.19M4.95M10.28M
Year ago sales418k462k2.51M4.95M
Sales growth (year/est)139.20%157.60%97.40%107.70%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.48-0.6-0.66-0.53
Actual EPS-0.84-0.71-0.6-0.53
Difference-0.36-0.110.060
Surprise %-75.00%-18.30%9.10%0.00%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.58-0.64-2.16-1.24
7 days ago-0.46-0.39-1.38-1.34
30 days ago-0.46-0.39-1.38-1.34
60 days ago00-1.23-1.12
90 days ago00-1.23-1.12
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.31.00%N/AN/AN/A
Next qtr.9.90%N/AN/AN/A
Current year17.60%N/AN/AN/A
Next year42.60%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A